Eisai and UCL Reach First Scientific Milestone in Neurodegenerative Disease Drug Discovery Collaboration
Validation of a novel therapeutic concept marks a first step towards a new therapy for the treatment of neurodegenerative disorders such as Alzheimer’s disease and related dementias.
The first scientific milestone in the validation of a novel therapeutic concept for the treatment of neurodegenerative disorders was recently achieved by leading researchers from UCL (University College London) and Eisai. This represents the first step towards the development of a potential new drug aimed at treating the underlying cause of disease in an area where significant unmet medical need persists.
To read the full press release click here.
For more information about Eisai:UCL collaboration click here.